摘要
背景:腹主动脉瘤(Aaa)影响约10%的大于或等于65岁患者,常与高血压、血脂异常及其他与生活方式有关的疾病有关。腹主动脉瘤的发生与动脉硬化性改变伴发慢性炎症有关。然而,与动脉粥样硬化相关的确切病理机制仍不确定,为什么只有特定人群/百分比的动脉硬化患者发生动脉瘤,以及糖尿病如何抑制动脉瘤的发展仍未得到解答。 目的:通过对人AAA组织的病理组织学分析,探讨一种新的AAA形成机制,并在此基础上建立与人AAA组织相似的AAA动物模型。 结果:最近我们发现主动脉节段血管狭窄表现为扩张,主动脉是我们循环系统中最大的动脉,在生理条件下,主动脉内层是通过从腔内血流中直接扩散营养物质来营养的,而外膜主要由静脉灌注,因此大血管壁内的小营养动脉及静脉的低灌注会导致缺氧和随后的炎症和主动脉壁组织变性,从而导致动脉瘤的形成。在此基础上,我们通过降低大血管壁内的小营养动脉及静脉到主动脉壁的血流量,建立了AAA动物模型,成功地复制了AAA动物模型,该模型与人的组织病理学观察结果不一致,并观察到血管外膜脂质成分的明显异常。 结论:主动脉壁低灌注可引起炎症性AAA,为治疗AAA提供了新的治疗靶点。
关键词: 低灌注,血管外膜,腹主动脉瘤,炎症,组织变性,新疗法。
图形摘要
Current Drug Targets
Title:Hypoperfusion of the Aortic Wall Secondary to Degeneration of Adventitial Vasa Vasorum Causes Abdominal Aortic Aneurysms
Volume: 19 Issue: 11
关键词: 低灌注,血管外膜,腹主动脉瘤,炎症,组织变性,新疗法。
摘要: Background: An abdominal aortic aneurysm (AAA), which affects approximately 10% of Japanese men aged ≥ 65 years, is frequently associated with hypertension, dyslipidemia, and other lifestyle- related diseases. The development of an AAA is attributed to chronic inflammation concomitant with arteriosclerotic changes. However, an accurate pathomechanism associated with AAA remains uncertain, and questions such as why only a particular group/percentage of patients with arteriosclerosis develop aneurysms and how diabetes suppresses aneurysm development remain unanswered.
Objective: We examined a novel mechanism to develop AAA based on histopathological findings following analysis of the human AAA tissues. Additionally, based on these findings, we developed a new animal model of AAA, in which the histopathological characteristics are similar to human AAA tissue.
Results: Recently, we identified stenosis of the vasa vasorum (VV) in aortic segments showing dilatation. The aorta is the largest artery in our circulatory system. Under physiological conditions, the inner layer of the aorta is nourished via direct diffusion of nutrients from the luminal blood flow, whereas the outer adventitia is primarily perfused by the VV. Therefore, hypoperfusion of the VV induces hypoxia and subsequent inflammation and tissue degeneration of the aortic wall, resulting in aneurysm formation.
Based on these findings, we established an AAA animal model by reducing the blood flow through the VV to the aortic wall. AAA was successfully reproduced in our animal model. Histopathological findings in this model were indistinguishable from those observed in humans, and pronounced abnormality in lipid composition in blood vessel adventitia was also observed.
Conclusion: Thus, hypoperfusion of the aortic wall appeared to be sufficient to cause inflammationinduced AAA. These findings may provide potential targets for novel therapeutics for the management of an AAA.
Export Options
About this article
Cite this article as:
Hypoperfusion of the Aortic Wall Secondary to Degeneration of Adventitial Vasa Vasorum Causes Abdominal Aortic Aneurysms, Current Drug Targets 2018; 19 (11) . https://dx.doi.org/10.2174/1389450119666180122154409
DOI https://dx.doi.org/10.2174/1389450119666180122154409 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Statins: A Valuable Tool for the Prevention/Regression of Abdominal Aortic Aneurysms
Vascular Disease Prevention (Discontinued) Aneurysm of the Communicating Vein Between the Left Renal Vein and Left Ascending Lumbar Vein Mimicking Retroperitoneal Lymphadenopathy: A Case Report
Current Medical Imaging Systemic Inflammatory Response, Bacterial Translocation and Nitric Oxide Donors
Inflammation & Allergy - Drug Targets (Discontinued) Role of Chitosan Biomaterials in Drug Delivery Systems: A Patent Perspective
Recent Patents on Materials Science Role of MMPs in Metastatic Dissemination: Implications for Therapeutic Advances
Current Pharmaceutical Biotechnology Biologic Therapy and Treatment Options in Diabetic Retinopathy with Diabetic Macular Edema
Current Drug Safety Targeting PPAR Isoforms Following CNS Injury
Current Drug Targets Pharmaceutical Interventions to Influence Arteriogenesis: New Concepts to Treat Ischemic Heart Disease
Current Medicinal Chemistry COMPLICATIONS OF RECANALIZATION OF CHRONIC TOTAL OCCLUSION
Current Cardiology Reviews Effect of Long Chain n-3 PUFA on Endothelial Activation, Endothelial Function and Atheromatous Plaque Stability
Current Nutrition & Food Science Value of Real Time Three Dimensional Transesophageal Echocardiography in General Cardiology Practice
Recent Patents on Medical Imaging Transcatheter Aortic Valve Implantation Infective Endocarditis: Current Data and Implications on Prophylaxis and Management
Current Pharmaceutical Design Chymase as an Important Target for Preventing Complications of Metabolic Syndrome
Current Medicinal Chemistry The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases
Current Vascular Pharmacology Therapy Against Ischemic Injury
Current Pharmaceutical Design Reducing the Risk of Major Elective Non-cardiac Surgery: Is there a Role for Levosimendan in the Preoperative Optimization of Cardiac Function?
Current Drug Targets All for Statins and Statins for All; An Update
Current Pharmaceutical Design Angiotensin II and Abdominal Aortic Aneurysms: An update
Current Pharmaceutical Design The Extracellular Matrix of Blood Vessels
Current Pharmaceutical Design Human Urotensin II Promotes Hypertension and Atherosclerotic Cardiovascular Diseases
Current Medicinal Chemistry